Breast Cancer
Recent findings in breast cancer described by researchers from Copenhagen University
Published in OBGYN and Reproduction Week, February 15th, 2010
"in a multi-centre, randomised, controlled study, 1016 premenopausal women received seven series of FEC (F: fluorouracil, E: epirubicin and C: Cyclophosphamide) for early stage breast cancer. In the first series, all patients received standard dose (F: 600 mg/m(2), E: 60 mg/m(2) and C: 600 mg/m(2)). with leukocyte nadir 1.0-1.9 x 10(9)/l continued with standard dose for the remaining six series...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Columbia University's Mailman School of Public Health
Use of acetaminophen in pregnancy associated with increased asthma symptoms in children - Journal of the National Cancer Institute
News brief: Contrast agent with MRI improves detection of lymph nodes metastases - Journal of the National Cancer Institute
Symptoms have little value for early detection of ovarian cancer - Breast Cancer
Investigators at University of Marburg publish new data on breast cancer - Cancer Vaccines
Findings in cancer vaccines reported from P. Sabbatini and co-researchers - Carcinoma
Data on carcinoma reported by researchers at University of Maryland, Medical Department - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
